Unibest
← Back to patent-cliff list

CAS 107-13-1

2-Propenonitrileacrylonitrile

Codes: Molnupiravir-049, CINA-017, Urapidil-021

Application context (from source-drug indications)

COVID-19Molnupiravir呼吸道合胞体病毒感染MolnupiravirInfluenza virus infectionMolnupiravirRenal impairmentMolnupiravirHepatic function declineMolnupiravirHypercalcaemiaCinacalcet HydrochlorideSecondary hyperparathyroidismCinacalcet HydrochlorideHyperparathyroidismCinacalcet HydrochloridePrimary hyperparathyroidismCinacalcet HydrochlorideChronic renal impairmentCinacalcet HydrochlorideCardiogenic oedemaCinacalcet HydrochlorideHypertensionUrapidil hydrochloride

Source drugs (routes using this intermediate)

DrugTierExpiry
MolnupiravirTier B — Position early-
Cinacalcet HydrochlorideTier B — Position early-
Urapidil hydrochlorideTier C — Watch / trade-

Position in synthesis routes (up/downstream chain)

Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.

MolnupiravirOptimised routesteps: 3total yield: 245g(Molnupiravir)
3-(2-Oxoazepan-1-yl)propanenitrile→Azepan-2-one→2-Propenonitrile→1-(3-Aminopropyl)azepan-2-one
Urapidil hydrochlorideOptimised routesteps: 1total yield: 58.9g(Urapidil-022)

Intermediates available on this site

Side-by-side comparison of all listed offers on this CAS; price bands are list-price ranges, final price subject to RFQ confirmation.

SupplierProductPrice bandMOQLead timeQualificationsAction
Unibest Taizhou GMP-like Site((3aR,4R,6R,6aR)-6-(4-(hydroxyamino)-2-oxopyrimidin-1(2H)-yl)-2,2-dimethyltetrahydrofuro[3,4-d][1,3]dioxol-4-yl)methyl isobutyrate
Pharmaceutical Intermediates
On requestOn requestOn request
—

This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.